Alpha Paradigm Partners’s OptimizeRx OPRX Stock Holding History

Alpha Paradigm Partners’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-34,736	Closed	-$515K	–	576
2022 Q3	$515K	Buy	34,736 +13,314	+62%	+$263K	0.22%	154
2022 Q2	$587K	Buy	+21,422	New	+$635K	0.24%	150
2021 Q3	–	Sell	-12,001	Closed	-$743K	–	627
2021 Q2	$743K	Buy	+12,001	New	+$611K	0.28%	114
2021 Q1	–	Sell	-16,665	Closed	-$519K	–	597
2020 Q4	$519K	Buy	+16,665	New	+$408K	0.18%	145

Other funds holding OPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpha Paradigm Partners's OPRX Position: Q4 2022 in Review

Alpha Paradigm Partners sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 34,736 shares — an estimated $515K sold.

Alpha Paradigm Partners first reported a position in OPRX in Q4 2020 and held it in 4 quarters. The position peaked at $743K in Q2 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.

Alpha Paradigm Partners reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
Alpha Paradigm Partners sold 34,736 OptimizeRx shares in Q4 2022, an estimated $515K.
Alpha Paradigm Partners first reported a position in OptimizeRx in Q4 2020 and held it in 4 quarters.
Alpha Paradigm Partners's OptimizeRx position peaked at $743K in Q2 2021.
128 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.